61. AMA - Gene Therapy The Therapy Treated A Fouryear-old Child For Adenosine Deaminase (ADA) Deficiency, A Rare Genetic Disease In Which Children Are Born With Severe Immunodeficiency And Are Prone http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-mol

62. Treatment For Parkinson's, Treatment For Alzheimer's Pioneering genetic therapies for neurologic disorders. http://www.ceregene.com

Home Site Map Contact Directions Science Science at Ceregene Neurotrophic Factors Gene Delivery Technology Participate in a Clinical Trial PARKINSON'S DISEASE - Currently Enrolling ALZHEIMER'S DISEASE - Currently Enrolling Newsroom Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Disease Ceregene in the News: ... Learn More About Ceregene Clinical Trials Corporate Office: 9381 Judicial Drive, Suite 130 San Diego, CA 92121 T: 858-458-8800 F: 858-458-8801 llactid=13937

63. NHF | Bleeding Disorders Information Center | Gene Therapy: General Information Gene Therapy Pages gene therapy (main) gene therapy FAQ gene therapy articles gene therapy trials Gene Therapy Gene therapy represents a new field of medicine, one which can http://www.hemophilia.org/bdi/bdi_gene.htm

This section of our Web site sponsored by: Gene Therapy Pages: gene therapy (main) gene therapy FAQ gene therapy articles ( HemAware gene therapy trials Gene Therapy Gene therapy represents a new field of medicine, one which can potentially cure many genetic diseases such as bleeding disorders. Patients with inherited diseases such as hemophilia usually lack a functional protein, which can be replaced with periodic protein replacement therapy. An alternative is to add a normal gene to substitute for the defective one. The normal gene, if delivered to the right cells and in sufficient quantity, can continuously make the normal version of the defective protein, restoring normal clotting mechanisms. However, this is a new and highly experimental field. Many questions remain unanswered and will only be answered through a series of clinical studies, some of which are ongoing using the genes for factors VIII and IX. There have been many failures and disapointments when investigators have found that the technology for delivering the genes was inadequate when used in humans. Sometimes investigators have underestimated the complexity of the diseases they were attempting to cure. Because of some recent successes, hemophilia has emerged as the top candidate for a genetic disease most likely to benefit from gene therapy.

64. Gene Therapy Research Unit - The Children's Hospital At Westmead A joint initiative of The New Children s Hospital and the Children s Medical Research Institute is undertaking gene therapy clinical trials in Australia. Research projects include cancer immunotherapy, vector development, HIV infection, targeting gene delivery to specific tissue types. http://www.chw.edu.au/prof/services/genetherapy/

feedback sitemap gap for health telehealth ... Gene Therapy Research Unit Gene Therapy Research Unit A joint initiative of The Children's Hospital at Westmead and Children's Medical Research Institute Main Projects Publications Staff Contact Introduction The ultimate aim of biomedical research is to improve human health, but its more immediate impact, beyond the accumulation of biological knowledge, is an increase in our capacity to diagnose disease. Therapeutic benefits follow, but significantly more slowly. Herein lies a potentially frustrating paradox. When biomedical knowledge is undergoing rapid growth (as it is at present) we can anticipate a widening of the gap between our capacity to diagnose and our capacity to treat disease. For this reason it is fundamentally important that increased effort be focused on realising the therapeutic potential of advances in biological knowledge. Such an effort demands that we explore entirely new therapeutic paradigms and surmount the formidable translational challenges inherent in taking new therapies from the laboratory bench to the patient bedside. Gene Therapy, or "the use of genes as medicine" is one such paradigm, with immense but largely unrealised potential. The Gene Therapy Research Unit, a joint initiative of the The Children's Hospital at Westmead and

65. Alberta Gene Therapy Group A network of researchers looking to foster collaboration in several therapeutic fields. http://www.ualberta.ca/~britchie/agtg.html

The Alberta Gene Therapy Group The Alberta Gene Therapy Group began during a meeting organised by Lung-Ji Chang from the University of Alberta and Norman Wong from the University of Calgary held at the Holiday Inn, Red Deer, Alberta, November 23, Thursday, 1995. The group is not currently active.

66. Gene Therapy Ppt Presentation Gene Therapy is a new modality of medical Technology can be utilized in several disorders, A better understanding of the conseq.. A PowerPoint presentation http://www.authorstream.com/Presentation/doctorrao-210228-gene-therapy-entertain

67. Vektorologie Und Experimentelle Gentherapie - Startseite Group researching adenovirus-based approaches for the delivery of anti-cancer genes. http://www.gentherapie.med.uni-rostock.de/

Home Kontakt Forschung Publikationen Lehre ... Aktuelles VEKTOROLOGIE UND EXPERIMENTELLE GENTHERAPIE Kontakt I Impressum Tel.: +49 381 494 5066 Fax: +49 381 494 5062

68. Gene Therapy Clinical gene transfer had its official beginning when, in 1989, 5 patients with terminal melanoma were given autologous lymphocytes that had been marked ex vivo with a gene http://focosi.altervista.org/genetherapy.html

GENE THERAPY Table of contents : Principles of gene therapy in vivo gene therapy ex vivo ... Web resources Clinical gene transfer had its official beginning when, in 1989, 5 patients with terminal melanoma were given autologous lymphocytes that had been "marked" ex vivo with a gene encoding resistance to the antibiotic G418. This study was designed primarily to trace the cells in the patients' bodies and to show the safety of gene transfer, and in that sense it was successful. No helper viruses were found, no reverse transcriptase activity was detected, no toxicity was experienced, and the transduced cells remained otherwise "normal" ref Principles of gene therapy Gene therapy consists of altering cell genotype by transfecting polynucleotides ... ... directly into body cells ( in vivo gene therapy ... into cells extracted, cultured in vitro , transfected, selected (also against deleterious insertional mutagenesis !) and then re-inserted into the donor's body ( ex vivo gene therapy , sometimes wrongly called in vitro gene therapy) : please note that not all cell types can be extracted from the body (e.g. neurons) and/or cultured

69. Types Of Treatment - Gene Therapy - MD Anderson Cancer Center The human cancer gene prevention and therapy program conducts basic research, clinical trials and vector development. http://www.mdanderson.org/patient-and-cancer-information/cancer-information/canc

Skip to Content International Center English Español ... Events Keyword Home Patient and Cancer Information Cancer Information Cancer Topics ... Glossary of Cancer Terms Our Publications Keep up with the latest in cancer treatment, research, education and prevention. Subscribe Our Online Community Facebook Twitter YouTube iTunes U Gene Therapy Much of today's cancer research is devoted to finding missing or defective genes that cause cancer or increase an individual's risk for certain types of cancer. Gene research at MD Anderson has resulted in many important discoveries. We identified the mutated multiple advanced cancers gene (MMAC1) involved in some common cancers. We also performed the first successful correction of a defective tumor suppressor gene (p53) in human lung cancer. Current gene therapies are experimental, and many are still tested only on animals. There are some clinical trials involving a very small number of human subjects. The potential benefits of gene therapy are two-fold: Gene-based treatments can attack existing cancer at the molecular level, eliminating the need for drugs, radiation or surgery Identifying cancer susceptibility genes in individuals or families can have a major role in preventing the disease before it occurs The focus of most gene therapy research is the replacement of a missing or defective gene with a functional, healthy copy, which is delivered to target cells with a "vector." Viruses are commonly used as vectors because of their ability to penetrate a cell’s DNA. These vector viruses are inactivated so they cannot reproduce and cause disease. Gene transfer therapy can be done outside the body (ex vivo) by extracting bone marrow or blood from the patient and growing the cells in a laboratory. The corrected copy of the gene is introduced and allowed to penetrate the cells’ DNA before being injected back into the body. Gene transfers can also be done directly inside the patient’s body (in vivo).

70. Gene Therapy - MayoClinic.com Gene therapy — Overview covers definition, risk, results of this experimental procedure. http://www.mayoclinic.com/health/gene-therapy/MY00105

71. The Journal Of Gene Medicine - Wiley Online Library Publishes articles on the science of gene transfer and its clinical applications and is the official journal of the European Society of Gene Therapy. http://www3.interscience.wiley.com/journal/10009391/home

document.documentElement.className = "js_en"; Skip to Main Content Home Help PUBLICATIONS ... ABOUT US LOGIN Enter e-mail address Enter password REMEMBER ME NOT REGISTERED ? FORGOTTEN PASSWORD ? JOURNAL TOOLS Get New Content Alerts Get RSS feed Save to My Profile Get Sample Copy JOURNAL MENU Journal Home FIND ISSUES Current Issue All Issues Virtual Issues FIND ARTICLES Early View GET ACCESS Subscribe / Renew FOR CONTRIBUTORS Author Guidelines OnlineOpen Submit an Article ABOUT THIS JOURNAL Society Information Overview Editorial Board Advertise ... Contact SPECIAL FEATURES Other Resources Gene Therapy Clinical Trials Worldwide Database Supporting Information The Journal of Gene Medicine Edited by: Shigetaka Asano, Olivier Danos, Kay Davies, Pierre Lehn, Richard Mulligan Impact Factor: 2.968 Online ISSN: Recently Published Issues See all Current Issue: October 2010 Volume 12, Issue 10 September 2010 Volume 12, Issue 9 August 2010 Volume 12, Issue 8 July 2010 Volume 12, Issue 7 June 2010 Volume 12, Issue 6 Database The Review Gene Therapy More Resources Clinical Trials The Database Free Content Virtual Issues Online-only The Journal of Gene Medicine will be Online-only commencing January 2011.

72. Gene Therapy Essays And Articles At ENotes Gene Therapy essays, articles, and viewpoints Gene therapy is based on the concept that genetic disorders and acquired diseases can be treated by replacing abnormal or absent genes http://www.enotes.com/gene-therapy-article

73. Gene Therapy - Biotechnology - Science And Research Describes gene therapy and its applications in treating genetic diseases http://www.hc-sc.gc.ca/sr-sr/biotech/about-apropos/gen_therap-eng.php

74. Www.gtmb.org Free access online journal that publishes articles and reviews relating to the clinical applications of molecular biology. http://www.gtmb.org/

75. Gene Therapy — PNAS Mark A. Kay *, †, Dexi Liu ‡, and Peter M. Hoogerbrugge * Division of Medical Genetics, Department of Medicine, University http://www.pnas.org/content/94/24/12744.full

var callbackToken='511DE4A3D26073F'; PNAS Proceedings of the National Academy of Sciences of the United States of America Skip to main page content Info for Authors ... Site Map Gene therapy Mark A. Kay Dexi Liu , and Peter M. Hoogerbrugge Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195; Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261; and Department of Pediatrics, University of Leiden, Leiden, The Netherlands Next Section Abstract In recent years, there have been a number of technological breakthroughs that have allowed for clinical trials in gene therapy to be initiated. In combination with the genome initiative, the potential for new therapeutics is limitless. Although an enormous amount of information has been obtained in a relatively short period of time, gene therapy is not yet ready for wide-scale practice. Some of the successes and obstacles that remain are summarized in this report. Previous Section Next Section Gene Therapy: The Problem Gene therapy can be defined as the introduction of nucleic acids into cells for the purpose of altering the course of a medical condition or disease. In general, with some exceptions, the nucleic acids are DNA molecules encoding gene products or proteins. The original ideas were directed toward treating monogenic (single-gene) disorders, but it has become clear that the gene can be considered a new pharmaceutical agent for treating many types of diseases. Over the last 20 years, the initial thoughts of gene therapy have been transformed into reality with more than 175 clinical trials and 2,000 patients already treated (

76. Human Gene Therapy Publishes scientific papers on original investigations into the transfer and expression of genes in mammals, including humans. Subscription based. http://www.liebertpub.com/Products/Product.aspx?pid=19

77. Gene Therapy I Disease Genetic defect; hemophilia A absence of clotting factor VIII cystic fibrosis defective chloride channel protein muscular dystrophy defective muscle protein http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/G/GeneTherapy.html

Index to this page Severe Combined Immunodeficiency (SCID) Treatment Options: Gene Therapy: requirements Target Cells ... Adenovirus Vectors Gene Therapy I Many human diseases are caused by defective genes. A few common examples: Disease Genetic defect hemophilia A absence of clotting factor VIII cystic fibrosis defective chloride channel protein muscular dystrophy defective muscle protein (dystrophin) sickle-cell disease defective beta globin hemophilia B absence of clotting factor IX severe combined immunodeficiency (SCID) any one of several genes fail to make a protein essential for T and B cell function All of these diseases are caused by a defect at a single gene locus . (The inheritance is recessive so both the maternal and paternal copies of the gene must be defective.) Is there any hope of introducing functioning genes into these patients to correct their disorder? Probably. Other diseases, also have a genetic basis, but it appears that several genes must act in concert to produce the disease phenotype . The prospects of gene therapy in these cases seems far more remote. Case study: severe combined immunodeficiency (SCID) SCID is a disease in which the patient has neither cell-mediated immune responses nor is able to make antibodies It is a disease of young children because, until recently, the absence of an immune system left them prey to infections that ultimately killed them.

78. Oxford BioMedica Focuses on developing gene transfer technologies for human gene therapy, gene-based immunotherapy, and gene-based drug discovery for cancer, AIDS, neurodegenerative and cardiovascular disease. http://www.oxfordbiomedica.co.uk/

79. GENE THERAPY. - Free Online Library Free Online Library GENE THERAPY. by The Exceptional Parent ; Consumer news, advice, product reviews Education Family and marriage Gene therapy Evaluation Ornithine http://www.thefreelibrary.com/GENE THERAPY-a060875635

CacheBuster('') Printer Friendly 18,321,456 articles and books Periodicals Literature Keyword Title Author Topic Member login User name Password Remember me Join us Forgot password? Submit articles free The Free Library ... The Exceptional Parent artId=60875635;usrSelf=false; GENE THERAPY. Balancing the Promise With the Reality On September 17, 1999, four days after receiving a gene therapy infusion at the University of Pennsylvania (body, education) University of Pennsylvania - The home of ENIAC and Machiavelli. http://upenn.edu/. Address: Philadelphia, PA, USA. , a young man from Arizona who had a genetic disease known as Ornithine Transcarbamylase Deficiency ornithine transcarbamylase deficiency OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) died. His deaththe first that could be directly linked to gene therapyelectrified the scientific community and triggered a national debate that will have a powerful impact on the future of gene therapy experiments and how they are approved and monitored. These are profound and important questions left unanswered, but for Jesse Gelsinger Jesse Gelsinger (June 18 1981 - September 17 1999) was the first person publicly identified as having died in a clinical trial for gene therapy. He was 18 years old. Gelsinger suffered from ornithine transcarbamylase deficiency, an X-linked genetic disease of the liver, whose

80. KonsoleH :: Login Focused on developing gene therapies for lipoprotein lipase disorder, inflammatory bowel disease and neuroregeneration. Also provides contract development and manufacturing of gene and cell-based products in their GMP facility. http://www.amtbv.com/

Webmail Account-Administration Klicken Sie auf ein Icon, um sich anzumelden Impressum

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 100    Back | 1  | 2  | 3  | 4  | 5  | Next 20